Clinical trial

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

NCT06430541

Study summary

ClinicalTrials.gov

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Psilocybin Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-21

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Ovarian Cancerverified · MONDO: ovarian cancer

Interventions

PsilocybinDRUG

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Usona Institutecollaborator

Mapped research locations

AuroraColorado, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06430541 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.